Evaluating New Ophthalmic Digital Devices for Safety and Effectiveness in the Context of Rapid Technological Development

被引:10
|
作者
Bodnar, Zachary M. [1 ]
Schuchard, Ronald [2 ]
Myung, David [1 ]
Tarver, Michelle E. [2 ]
Blumenkranz, Mark S. [1 ]
Afshari, Natalie A. [3 ]
Humayun, Mark S. [4 ]
Morse, Christie [5 ]
Nischal, Ken [6 ]
Repka, Michael X. [7 ]
Sprunger, Derek [5 ]
Trese, Michael [7 ]
Eydelman, Malvina B. [2 ]
机构
[1] Stanford Univ, Byers Eye Inst, Dept Ophthalmol, Palo Alto, CA 94304 USA
[2] US FDA, Ctr Devices & Radiol Hlth, Div Ophthalm & ENT Devices, Silver Spring, MD USA
[3] Amer Soc Cataract & Refract Surg, FDA Comm, Cornea & Refract Surg, Fairfax, VA USA
[4] Amer Soc Retinal Specialists, Chicago, IL USA
[5] Amer Assoc Pediat Ophthalmol & Strabismus, San Francisco, CA USA
[6] Amer Acad Pediat, Sect Ophthalmol, Itasca, IL USA
[7] Amer Acad Ophthalmol, San Francisco, CA USA
关键词
VISUAL-FIELD PROGRESSION; DIABETIC-RETINOPATHY; PREMATURITY; DIAGNOSIS; GLAUCOMA; PROGRAM;
D O I
10.1001/jamaophthalmol.2019.1576
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Key PointsQuestionHow could ophthalmic digital devices be evaluated for safety and effectiveness to streamline innovation? FindingsThis Special Communication from a workshop on ophthalmic digital devices comprising regulators, health care practitioners, researchers, medical device firms, mobile application developers, patients, and other stakeholders concluded that because of the risks associated with automation are substantially increased in rapidly progressive diseases, criterion standards and expert graders are critically important in the evaluation of automated systems and telemedicine platforms. Training at all levels is important for the safe and effective operation of digital health devices, and to promote cybersecurity and protect patient privacy. MeaningWith appropriate validation against criterion standards, physician oversight, and robust cybersecurity protocols, digital health technology could improve screening and treatment of ophthalmic diseases and improve access to care. This Special Communication from The Ophthalmic Digital Health Workshop discusses the challenges of balancing providing patients with the most current innovations in ophthalmic digital health and maintaining appropriate safety and efficacy screening. ImportanceThe US Food and Drug Administration's medical device regulatory pathway was initially conceived with hardware devices in mind. The emerging market for ophthalmic digital devices necessitates an evolution of this paradigm. ObjectivesTo facilitate innovation in ophthalmic digital health with attention to safety and effectiveness. Evidence ReviewThis article presents a summary of the presentations, discussions, and literature review that occurred during a joint Ophthalmic Digital Health workshop of the American Academy of Ophthalmology, the American Academy of Pediatrics, the American Association for Pediatric Ophthalmology and Strabismus, the American Society of Cataract and Refractive Surgery, the American Society of Retina Specialists, the Byers Eye Institute at Stanford and the US Food and Drug Administration. FindingsCriterion standards and expert graders are critically important in the evaluation of automated systems and telemedicine platforms. Training at all levels is important for the safe and effective operation of digital health devices. The risks associated with automation are substantially increased in rapidly progressive diseases. Cybersecurity and patient privacy warrant meticulous attention. Conclusions and RelevanceWith appropriate attention to safety and effectiveness, digital health technology could improve screening and treatment of ophthalmic diseases and improve access to care.
引用
收藏
页码:939 / 944
页数:6
相关论文
共 50 条
  • [1] Evaluating the Safety and Effectiveness of New Drugs
    Pegler, Scott
    Underhill, Jonathan
    [J]. AMERICAN FAMILY PHYSICIAN, 2010, 82 (01) : 53 - 57
  • [2] Evaluating the Safety and Effectiveness of New Drugs
    Pegler, Scott
    Underhill, Jonathan
    [J]. OBSTETRICS AND GYNECOLOGY, 2010, 116 (06): : 1405 - 1409
  • [3] FDA Facilitating Innovation of Ophthalmic Devices While Balancing the Need for Safety and Effectiveness
    Nguyen, Tieuvi
    Hampton, Denise
    Eydelman, Malvina B.
    [J]. JAMA OPHTHALMOLOGY, 2022, 140 (04) : 309 - 311
  • [4] Safety and effectiveness comparison of a new cohesive ophthalmic viscosurgical device
    Packer, Mark
    Shultz, Mitchell
    Loden, James
    Lau, George
    [J]. JOURNAL OF CATARACT AND REFRACTIVE SURGERY, 2023, 49 (08): : 804 - 811
  • [5] New Cinema in the Context of the Technologies of Information and Communication and the New Technological Devices
    Zitello, Matias
    Zena, Marcela
    [J]. REVISTA GESTION DE LAS PERSONAS Y TECNOLOGIA, 2012, 5 (15): : 63 - 75
  • [6] Novel Model Development for Preclinical Safety Evaluation of Ophthalmic Viscosurgical Devices
    Huang, Ling C.
    Gray, Brad
    Leang, Ronika
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2018, 59 (09)
  • [7] TECHNOLOGICAL DEVELOPMENT AND EMPLOYMENT STRUCTURE IN CONTEXT OF ECONOMY DIGITAL TRANSFORMATION
    Akaev, Askar
    Sarygulov, Askar
    Petryakov, Alexander
    Podgornaya, Victoria
    [J]. COMPETITIVENESS AND THE DEVELOPMENT OF SOCIO-ECONOMIC SYSTEMS, 2021, 105 : 57 - 66
  • [8] Accelerating Innovation in Ophthalmic Digital Health New Frontiers for Medical Devices
    Bodnar, Zachary M.
    Tarver, Michelle E.
    Eydelman, Malvina
    [J]. JAMA OPHTHALMOLOGY, 2017, 135 (12) : 1291 - 1292
  • [9] An Enhanced Method for Evaluating the Effectiveness of Protective Devices for Road Safety Application
    Perticone, Alberto
    Barbani, Daniele
    Baldanzini, Niccolò
    [J]. SSRN, 2023,
  • [10] An enhanced method for evaluating the effectiveness of protective devices for road safety application
    Perticone, A.
    Barbani, D.
    Baldanzini, N.
    [J]. ACCIDENT ANALYSIS AND PREVENTION, 2024, 203